Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Reports by D. Bogaert and co-researchers describe recent advances in life sciences
April 1st, 2009
New research, 'Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model,' is the subject of a report. According to recent research from Netherlands, "Streptococcus pneumoniae colonization and invasive disease peak around the third and first birthdays, respectively, and decline thereafter. While these declines are attributable in part to immunity acquired via natural exposure, maturation of innate immune responses may also be involved." "A mucosally administered candidate whole-cell pneumococcal vaccine (WCV) containing killed pneumococcal antigen (WCA) plus a cholera toxin adjuvant protects against...
Source: Vaccine Weekly (2009-04-01)
|
